Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
NCT03427359
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG:
cisplatin, capecitabine
Sponsor
The University of Hong Kong-Shenzhen Hospital